Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Next-Generation Sequencing in Medicine (Upcoming)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact

Review Series

NF-kappaB in defense and disease

Series edited by Albert S. Baldwin Jr.

NF-kappaB is a primary effector of human disease. The series highlights the evolutionary conservation of the NF-kappaB pathway and its regulation as well as the diverse functions the transcription factor has in human health and disease.

Articles in series

Toll-like receptor–mediated NF-κB activation: a phylogenetically conserved paradigm in innate immunity
Guolong Zhang, Sankar Ghosh
Guolong Zhang, Sankar Ghosh
Published January 1, 2001
Citation Information: J Clin Invest. 2001;107(1):13-19. https://doi.org/10.1172/JCI11837.
View: Text | PDF

Toll-like receptor–mediated NF-κB activation: a phylogenetically conserved paradigm in innate immunity

  • Text
  • PDF
Abstract

Authors

Guolong Zhang, Sankar Ghosh

×

Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
Yumi Yamamoto, Richard B. Gaynor
Yumi Yamamoto, Richard B. Gaynor
Published January 15, 2001
Citation Information: J Clin Invest. 2001;107(2):135-142. https://doi.org/10.1172/JCI11914.
View: Text | PDF

Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer

  • Text
  • PDF
Abstract

Authors

Yumi Yamamoto, Richard B. Gaynor

×

Hostile takeovers: viral appropriation of the NF-kB pathway
John Hiscott, … , Hakju Kwon, Pierre Génin
John Hiscott, … , Hakju Kwon, Pierre Génin
Published January 15, 2001
Citation Information: J Clin Invest. 2001;107(2):143-151. https://doi.org/10.1172/JCI11918.
View: Text | PDF

Hostile takeovers: viral appropriation of the NF-kB pathway

  • Text
  • PDF
Abstract

Authors

John Hiscott, Hakju Kwon, Pierre Génin

×

Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
Albert S. Baldwin
Albert S. Baldwin
Published February 1, 2001
Citation Information: J Clin Invest. 2001;107(3):241-246. https://doi.org/10.1172/JCI11991.
View: Text | PDF

Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB

  • Text
  • PDF
Abstract

Authors

Albert S. Baldwin

×

NF-κB in neuronal plasticity and neurodegenerative disorders
Mark P. Mattson, Simonetta Camandola
Mark P. Mattson, Simonetta Camandola
Published February 1, 2001
Citation Information: J Clin Invest. 2001;107(3):247-254. https://doi.org/10.1172/JCI11916.
View: Text | PDF

NF-κB in neuronal plasticity and neurodegenerative disorders

  • Text
  • PDF
Abstract

Authors

Mark P. Mattson, Simonetta Camandola

×

NF-κB: pivotal mediator or innocent bystander in atherogenesis?
Tucker Collins, Myron I. Cybulsky
Tucker Collins, Myron I. Cybulsky
Published February 1, 2001
Citation Information: J Clin Invest. 2001;107(3):255-264. https://doi.org/10.1172/JCI10373.
View: Text | PDF

NF-κB: pivotal mediator or innocent bystander in atherogenesis?

  • Text
  • PDF
Abstract

Authors

Tucker Collins, Myron I. Cybulsky

×

Series Introduction: The transcription factor NF-κB and human disease
Albert S. Baldwin Jr.
Albert S. Baldwin Jr.
Published January 1, 2001
Citation Information: J Clin Invest. 2001;107(1):3-6. https://doi.org/10.1172/JCI11891.
View: Text | PDF

Series Introduction: The transcription factor NF-κB and human disease

  • Text
  • PDF
Abstract

Authors

Albert S. Baldwin Jr.

×

NF-κB: a key role in inflammatory diseases
Paul P. Tak, Gary S. Firestein
Paul P. Tak, Gary S. Firestein
Published January 1, 2001
Citation Information: J Clin Invest. 2001;107(1):7-11. https://doi.org/10.1172/JCI11830.
View: Text | PDF

NF-κB: a key role in inflammatory diseases

  • Text
  • PDF
Abstract

Authors

Paul P. Tak, Gary S. Firestein

×

Advertisement

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts